Companies

Acrux Limited: TSL raised $26.1 million through three capital raisings, advised on corporate structure and Board composition, and recruited appropriately qualified Directors. TSL also assisted with a successful START grant application, and provided company secretarial services and ongoing strategic business advice. MORE...

Origin Capital Limited: TSL established a Pooled Development Fund shell and raised $6 million for the Company.  TSL identified three investee companies in which Origin subsequently invested.  Origin has recently invested in a fourth investee company.

Dendritic Nanotechnology Limited: TSL prepared an information memorandum and conducted a business plan review.

Dental Focus: TSL provided an initial assessment of potential merger and acquisition opportunities.

Intreat Pty Ltd (now Canxell Ltd.): TSL provided corporate structuring and business planning advice.

Etech Group International Ltd: TSL provided corporate structuring and business planning advice and assisted in capital raising. MORE...

NeuroVu Research Pty Ltd: TSL prepared a business plan and assisted in an initial capital raising.

Healthfarm Fine Foods Pty Ltd: TSL advised on corporate restructuring, commercialisation and business planning, appointed a CEO, and negotiated and implemented the acquisition of a food manufacturing facility. TSL initiated the company's formation, assisted with the preparation of offer documentation and capital raisings.  TSL subsequently arranged the sale of the primary operations of the company to NuFarm Limited. MORE...

Plantic Technologies Limited: TSL raised an initial $6 million and a secondary raising of $5.5 million, prepared the initial business plan, recruited a CEO and independent Board, and provided company secretarial services. MORE...

Starpharma Holdings Limited: TSL raised $12.8 million through two capital raisings, advised on corporate structure and assisted with an IPO which raised $22.4 million. TSL also provided commercialisation and business development advice and shareholder liaison services. MORE...

Stem Cell Sciences Limited: TSL provided corporate and strategic advice including corporate structuring, employee remuneration planning and preparation of a business plan. TSL assisted with a substantial capital raising from a consortium of leading private equity funds. MORE...

Virax Holdings Limited: TSL raised $7 million through two capital raisings and provided corporate advisory services, including preparation for IPO. MORE...

Diagnotech Pty Ltd: Provided structuring and strategic advice.

PharmaQest Pty Ltd: Provided structuring and strategic advice and negotiated an international collaboration with the Sigma Tau Group.

Micronix Pty Ltd: Provided structuring and strategic advice and conducted two capital raisings for the company. MORE...

Horizon Science Pty Ltd: Provided structuring and strategic advice on commercialisation of the company’s technology.  Introduced $9 million capital through Inventages and Bio Pacific Ventures.  Inventages is partially funded by the multinational Nestlé group. MORE...

TPI Enterprises Limited:  An Australian company that has been formed to commercialise technology for the international pharmaceutical industry.  TSL raised $7 million capital and provided structuring and strategic advice.  TSL also provided assistance in negotiations with government, regulatory bodies and prospective customers. MORE...

Research organisations and institutions

CRC for polymers: TSL provided commercialisation advice and undertook a market assessment for a spinout company.

CRC for International Food Manufacture and Packaging Science: TSL established spin-out company (Plantic Technologies Limited) and negotiated technology transfer and research agreements

Flinders University: TSL prepared an application for a licence under the Pre-Seed Fund Program on behalf of three South Australian universities

Genomic Disorders Research Centre: TSL advised on various commercialisation issues.

Monash University: TSL established a spin-out company (Acrux Limited) based on a proprietary technology platform from the Victorian College of Pharmacy

Murdoch Children's Research Institute: TSL created a business model for a spin-out company as part of the Institute's commercialisation strategy

Swinburne University: TSL provided strategic advice on financing research programs and facilities

Government and funding agencies

Geoffrey Gardiner Dairy Foundation: TSL developed guidelines, selection criteria, procedures and application forms for large, directed research and development projects

National Food Industry Strategy: TSL prepared a consulting report in relation to the proposed grant funding program.

State Government of Australia: TSL has undertaken a range of business plan and business reviews to support the government’s science, technology and innovation initiative.

Investors and service providers

Austock Brokers Proprietary Limited: TSL provided a commercial assessment of a potential investment opportunity

Deutsche Bank: TSL entered into a joint venture arrangement providing Deutsche Bank with a "first look" at potential Australian life sciences investment opportunities

Foley & Lardner: TSL provided local representation at a workshop for the Commonwealth Government's Biotechnology Centres of Excellence Program

Hochma Development Fund Limited: TSL provided a commercial and technical assessment of a potential investment opportunity

Jawcamb Australia Limited: TSL provided a commercial and technical assessment of a potential investment opportunity